More Than 50 New Medicines for HIV treatment to be Developed

17 July 2017 09:36

More  than 50 new drugs for HIV treatment are developed all over the World, said the Medicines in Development report by The Pharmaceutical Research and Manufacturers of America (PhRMA).

The majority of people living with HIV take not only one drug, but use combination of two or three drugs in one pill. Using one pill is easier - patient have few chances to forget about his drug intake and a few chances to improve his health and to increase the drug adherence.

Now there are about 45 drugs for HIv treatment and care approved in the USA, more than 50 new medicines are being developed. New medicines will be useful not only for HIV-positive patients, but also for broader public health, biopharmaceutical industry and health care community.

“Thanks to the hard work and dedication of countless individuals – from biopharmaceutical researchers, to those patients enrolled in clinical trials – we have seen an 88 percent decline in the HIV/AIDS death rate since the 1990s, and an estimated 862,000 premature HIV/AIDS deaths have been prevented in the United States. While we have made great progress, there is more to be done, which is why the 52 medicines and vaccines in development offer tremendous hope and inspiration that an AIDS-free generation may one day be in reach.” - said Stephen J. Ubl, president and chief executive officer of PhRMA.


Share with Telegram

Latest News

New Findings Shed Light on How HIV-Blocking Antibodies are Generated

New data illuminate how some human beings generate powerful, HIV-blocking antibodies. The results offer important insight into a potential AIDS vaccine design.

23 November 13:36

HIV-Positive Are Under-Treated for Cardiovascular Problems

People with both HIV and risk factors for heart disease and stroke were less likely to be treated with cholesterol-lowering statin drugs and aspirin than patients without HIV.

23 November 10:35

“Digital bathhouses”: Health experts see dating apps as the new frontier for STD

“Because these are closed pools of people in limited geographies using dating apps, it means that infections can spread more easily,” said Michael Weinstein, the president of the AIDS Healthcare Foundation. “That’s why we call apps a ‘digital bathhouse’.”

22 November 15:37

FDA approves first two-drug regimen for patients with HIV-1

FDA approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1).

22 November 08:10